Clinical and Molecular Hepatology

"Pandemic"

Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”: Jeayeon Park, Su Jong Yu; Clin Mol Hepatol 2025;31(2):e221-e223.
Published online March 4, 2025; DOI: https://doi.org/10.3350/cmh.2025.0226

Editorial

Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD through the COVID-19 pandemic: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”: Jeayeon Park, Su Jong Yu; Clin Mol Hepatol 2025;31(2):625-627.
Published online January 16, 2025; DOI: https://doi.org/10.3350/cmh.2025.0019

Citations

Citations to this article as recorded by

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clinical and Molecular Hepatology.2025; 31(2): e183. CrossRef
Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Jeayeon Park, Su Jong Yu
Clinical and Molecular Hepatology.2025; 31(2): e221. CrossRef